FDA Clarifies Expectations for Completeness Assessments for Drug Master Files

FDA has clarified its requirements for DMF completeness acceptance following complaints that the draft guidance was too vague. FDA elaborates on what constitutes a single drug substance, single manufacturing process and starting materials.